Life sciences news

Biocair moves into new Frankfurt office, continuing global expansion

Thursday June 17th 2021

Read more
Commercial Agency Agreement between Ardena and South Korean company Keyfronbio Co., Ltd.

Wednesday June 16th 2021

Read more
Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels

Tuesday June 15th 2021

Read more
Vacature: Manager Studiedienst (m/v/x) bij flanders.bio

Monday June 14th 2021

Read more
Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics

Monday June 14th 2021

Read more
Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™

Monday June 14th 2021

Read more
OXURION confirms Institutional Review Board approval and submission of the Investigational New Drug Application to the FDA to start Phase 2 Study evaluating THR-687 for Diabetic Macular Edema (DME)

Thursday June 10th 2021

Read more
Biotalys nominates Catherine Moukheibir to its Board of Directors

Thursday June 10th 2021

Read more
Your news here?

Become a flanders.bio member
argenx to regain global rights to cusatuzumab

Tuesday June 8th 2021

Read more
OXURION completes patient enrollment for Part A of Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

Tuesday June 8th 2021

Read more
SELECTION study on filgotinib in ulcerative colitis published in The Lancet

Friday June 4th 2021

Read more

More info?

Communication Coordinator